Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
FI772551A7 - NYA 0-(3-AMINO-2-HYDROXI-PROPYL)-AMIDOXIM-DERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH FARMACEUTISKA KOMPOSITIONER SOM INNEHAOLLER DEM - Google Patents
[go: Go Back, main page]

FI772551A7 - NYA 0-(3-AMINO-2-HYDROXI-PROPYL)-AMIDOXIM-DERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH FARMACEUTISKA KOMPOSITIONER SOM INNEHAOLLER DEM - Google Patents

NYA 0-(3-AMINO-2-HYDROXI-PROPYL)-AMIDOXIM-DERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH FARMACEUTISKA KOMPOSITIONER SOM INNEHAOLLER DEM

Info

Publication number
FI772551A7
FI772551A7 FI772551A FI772551A FI772551A7 FI 772551 A7 FI772551 A7 FI 772551A7 FI 772551 A FI772551 A FI 772551A FI 772551 A FI772551 A FI 772551A FI 772551 A7 FI772551 A7 FI 772551A7
Authority
FI
Finland
Prior art keywords
farmaceutiska
kompositioner
amidoxim
hydroxi
derivat
Prior art date
Application number
FI772551A
Other languages
Finnish (fi)
Other versions
FI68396C (en
FI68396B (en
Inventor
Kalman Takacs
Nagy Peter Literati
Ajzert Ilona Kiss
Antal Simay
Matyas Szentivanyi
Sandor Virag
Botos Katalin Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI772551A7 publication Critical patent/FI772551A7/en
Application granted granted Critical
Publication of FI68396B publication Critical patent/FI68396B/en
Publication of FI68396C publication Critical patent/FI68396C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI772551A 1976-08-27 1977-08-26 PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC ANVAENDBARA 0- (3-AMINO-2-HYDROXY-PROPYL) -AMIDOXIMDERIVAT FI68396C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUCI001682 1976-08-27
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (3)

Publication Number Publication Date
FI772551A7 true FI772551A7 (en) 1978-02-28
FI68396B FI68396B (en) 1985-05-31
FI68396C FI68396C (en) 1985-09-10

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772551A FI68396C (en) 1976-08-27 1977-08-26 PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC ANVAENDBARA 0- (3-AMINO-2-HYDROXY-PROPYL) -AMIDOXIMDERIVAT

Country Status (23)

Country Link
JP (1) JPS5350131A (en)
AT (1) AT355554B (en)
AU (1) AU521432B2 (en)
BE (1) BE858134A (en)
CA (1) CA1077506A (en)
CH (1) CH630344A5 (en)
CS (1) CS204008B2 (en)
DD (1) DD132433A5 (en)
DE (1) DE2738589A1 (en)
DK (1) DK150196C (en)
ES (1) ES462346A1 (en)
FI (1) FI68396C (en)
FR (1) FR2362845A1 (en)
GB (1) GB1582029A (en)
GR (1) GR63623B (en)
HU (1) HU177578B (en)
IL (1) IL52804A (en)
NL (1) NL187478C (en)
NO (1) NO144793C (en)
PL (1) PL107628B1 (en)
SE (1) SE435280B (en)
SU (1) SU730296A3 (en)
YU (2) YU202377A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
JPH01169445A (en) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd Focal distance switching camera
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (en) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hydroxylamine derivatives and use thereof in the preparation of a pharmaceutical compositions for enhancing of molecular chaperon production of cells
HUT78139A (en) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Composition for reducing skin state aging
HUP9602204D0 (en) * 1996-08-09 1996-10-28 Biorex Rt Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
HUP0103714A3 (en) 1998-05-11 2003-05-28 Takeda Pharmaceutical Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
JP2005514418A (en) 2002-01-11 2005-05-19 ビオレックス クタトー エス フェイレストェー アールテー. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
KR20230128462A (en) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 Process for preparing arimoclomol citrate and intermediates thereof

Also Published As

Publication number Publication date
GR63623B (en) 1979-11-27
BE858134A (en) 1977-12-16
FI68396C (en) 1985-09-10
YU237782A (en) 1983-12-31
SE7709482L (en) 1978-02-28
DE2738589A1 (en) 1978-03-02
FR2362845A1 (en) 1978-03-24
CH630344A5 (en) 1982-06-15
DD132433A5 (en) 1978-09-27
SU730296A3 (en) 1980-04-25
SE435280B (en) 1984-09-17
DK379777A (en) 1978-02-28
NO772958L (en) 1978-02-28
DK150196C (en) 1987-07-06
FR2362845B1 (en) 1981-01-09
CA1077506A (en) 1980-05-13
CS204008B2 (en) 1981-03-31
NL7709276A (en) 1978-03-01
JPS6216942B2 (en) 1987-04-15
ES462346A1 (en) 1978-06-16
DK150196B (en) 1987-01-05
AU2825477A (en) 1979-03-01
JPS5350131A (en) 1978-05-08
AU521432B2 (en) 1982-04-01
PL107628B1 (en) 1980-02-29
HU177578B (en) 1981-11-28
IL52804A (en) 1981-06-29
NO144793B (en) 1981-08-03
NO144793C (en) 1981-11-11
IL52804A0 (en) 1977-10-31
AT355554B (en) 1980-03-10
GB1582029A (en) 1980-12-31
YU202377A (en) 1983-12-31
NL187478C (en) 1991-10-16
FI68396B (en) 1985-05-31
ATA605477A (en) 1979-08-15

Similar Documents

Publication Publication Date Title
FI773384A7 (en) ANORDNING SOM BILDAR EN OEVERMATNINGSGRUPP FOER FOERBRAENNINGSMOTORER
FI773595A7 (en) NYA ORGANISKA FOERENINGAR DERAS FRAMSTAELLNING OCH ANVAENDNING
FI772823A7 (en) NYA 1-ARYLOXI-HYDROXI-3-ALKYLENAMINOPROPANER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI772642A7 (en) THIAZOLIDINDERIVAT OCH FOERFARANDE FOER FRAMSTAELLNING AV DEM
FI773060A7 (en) HYDANTOINDERIVAT SOM LAEKEMEDEL
FI793688A7 (en) HYDROXIPROPYL-TRIAZOL FOERFARANDE FOER FRAMSTAELLNING AV DEM OCH DERAS ANVAENDNING SOM LAEKEMEDEL
FI773905A7 (en) YTSTRUKTUR AV POLYURETAN SOM UPPTAR OCH GENOMSLAEPPER VATTENAONGA
FI772719A7 (en) OEVERDRAG SOM GARANTERAR EN KONTROLLERAD FRIGOERING AV AKTIVA INGREDIENSER UR BIOLOGISKT AKTIVA KOMPOSITIONER SPECIELLT UR FARMACEUTISKA KOMPOSITIONER OCH FOERFARANDE FOER FRAMSTAELLNING AV BIOLOGISKT AKTIVA KOMPOSITIONER SOM GARANTERAR EN KONTROLLERAD FRIGOERING AV AKTIVA INGREDIENSER
FI773904A7 (en) YTSTRUKTUR AV POLYURETAN SOM UPPTAR OCH GENOMSLAEPPER VATTENAONGA
FI772551A7 (en) NYA 0-(3-AMINO-2-HYDROXI-PROPYL)-AMIDOXIM-DERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH FARMACEUTISKA KOMPOSITIONER SOM INNEHAOLLER DEM
FI793201A7 (en) PAPPERS KALANDERINGSFOERFARANDE FOER PAPPER OCH KALANDER SOM TILLAEMPAR FOERFARANDE
FI773353A7 (en) NYA 0-ALKYLERADE HYDROXYLAMINER FOERFARANDET FOER FRAMSTAELLNING AV DEM OCH DERAS ANVAENDNING
FI773637A7 (en) I HYDROFOBA OCH HYDROFILA MEDIER LAETT FOERDELBARA FLOCKULERINGSSTABILA FASTAEMNESDISPERSIONER OCH ANVAENDANDET AV DEM
FI803253L (en) BENSODIAZEPINFOERENINGAR OCH DERAS ANVAENDNING SOM LAEKEMEDEL
FI772594A7 (en) NYA URACILFOERENINGAR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI792832A7 (en) NYA N-PYRROLYL-PYRIDAZINAMINER FOERFARANDE FOER FRAMSTAELLNING AV DEM OCH DERAS ANVAENDNING SOM ANTIHYPERTENSIVA AEMNEN
FI783150A7 (en) SPAENNINGSKAELLE SOM FOERSTAERKER OCH STABILISERAR SPAENNINGEN
FI782316A7 (en) NEW MALEINMID- OCH SUCCINIMIDDERIVAT OCH FOERFARANDE FOER FRAMSTAELLNING AV DEM
FI773273A7 (en) NYA ORGANISKA FOERENINGAR DERAS FRAMSTAELLNING OCH ANVAENDNING
FI781872A7 (en) NYA BISPIDINDERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH LAEKEMEDEL SOM INNEHAOLLER DESSA FOERENINGAR
FI773766A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV KOELDBESTAENDIGA POROESA OCH VATTENGENOMSLAEPPANDE PLATTOR SOM LAEMPAR SIG FOER ATT BEKLAEDA JORDYTOR OCH SAOLUNDA FRAMSTAELLDA PLATTOR
FI773368A7 (en) SUBSTITUERADE O-PHENYLENEDIAMINDERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL
FI773902A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV 0-ALKYLERADE OXIMER OCH DERAS ANVAENDNING SOM LAEKEMEDEL
FI782107A7 (en) BIS-TRIAZINYLAMINOSTILBENFOERENINGAR FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM OPTISKA VITMEDEL
FI773903A7 (en) NYA BASISKT SUBSTITUERADE 0-PROPYLOXIMER FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK